Latest News
Blue Ox Healthcare Partners (Blue Ox), an investment firm focused on providing growth capital to healthcare companies in the middle market, has led a USD52 million Series E investment in Epic Sciences (Epic), a diagnostics company developing solutions to personalise and advance cancer treatment and management.
Proceeds from the fundraising round are expected to be used to accelerate Epic’s clinical studies for oncology decision support services in its pipeline and execution of its long-term growth plan.
Based in San Diego, Epic is transforming late-stage cancer treatment by applying computer vision and machine learning techniques to match patients’ individual cancer
White Oak Global Advisors has held the close of the White Oak Yield Spectrum Fund to outside investors, with approximately USD2.1 billion of total commitments, exceeding the USD1.75 billion fundraising target.
White Oak’s previous flagship fund, the White Oak Summit Fund, closed with approximately USD1.3 billion of commitments in March 2016.
The capital for the White Oak Yield Spectrum Fund was raised from a diversified group of institutional investors worldwide. In particular, the Fund attracted very strong support from public and private pension funds, insurance companies and global family offices. White Oak currently manages over USD5.6 billion of committed
Ultimus Fund Solutions, an independent provider of mutual fund, private fund, pooled investment and middle office services, has completed the integration and brand transition of Woodfield Fund Administration, following the acquisition of the private fund administration firm in April.
As a result, Ultimus has expanded its offering to include fund administration services for various private fund structures such as private equity, venture capital, real estate and hedge funds.
As a fully integrated firm, Ultimus is able to better leverage technology investments, resources and assets, providing current and prospective clients the opportunity to access a wider range of services from
Innovia Medical (Innovia), Shore Capital Partners’ specialty surgical products platform, has acquired with Eagle Laboratories (Eagle Labs), a manufacturer and distributor of ophthalmic products, focusing on single-use cannula, micro-surgical knives, and blades.
“Since their founding over 28 years ago, Eagle Labs has established themselves as a best-in-class supplier of ophthalmic cannula, knives, and blades, becoming a trusted partner and market leader in the industry. We are impressed with what the De Camp family and their team have accomplished and are excited to partner with them in the next stage of growth,” says Terry Meredith, Chief Executive Officer of Innovia.
High Road Capital Partners’ portfolio company U-C Coatings has completed the acquisition of Contechem. The deal marks High Road’s 50th transaction.
The two companies provide complementary products for protecting freshly cut lumber and logs. Based in Portland, Oregon, Contechem is a leading manufacturer of wood protection products. Contechem’s Britewood anti-stain products inhibit mould growth and discoloration on wood and lumber, and the company’s proprietary application technology and equipment reduce waste and enhance worker safety.
“Joining Contechem’s innovative sapstain products with U-C Coatings’ industry-leading wood sealants and end paints provides an ideal cross-selling opportunity and one-stop shop package to customers,”
An affiliate of HIG Capital has completed the acquisition of Reliant Rehabilitation Holdings, a provider of therapy services to skilled nursing facilities.
Headquartered in Plano, TX, Reliant is one of the largest providers of contract therapy services in the United States. The Company utilises a proprietary care model that emphasises early intervention/assessment, properly designed clinical care plans and pathways to improve patients’ functional levels. Reliant differentiates itself by possessing best-in-class therapist recruitment, program performance management, customer marketing support and industry-leading compliance systems.
Chris Bird, Chief Executive Officer of Reliant, says: “We’re excited to partner with HIG for the next
David Hall of the Philipp Family Office, Mark Stephens of Blackstar Capital and Morgan Metters, previously of Kimura Capital, have joined forces to create Blackstar Asset Management, a UK based investment advisor.
With Swiss family office seed capital, the firm will focus on sustainable private debt strategies such as direct loans, deal participation and niche private fund opportunities.
The new firm will benefit from the established deal origination and structuring capacity of the experienced Blackstar Trade Finance team, and the wider Blackstar Group will benefit from increased funding sources.
“We are extremely excited about this new partnership,” says
For the second year running, Intralinks and Global Fund Media have collaborated to produce an in-depth survey on how global LPs view alternative investment opportunities over the next 12 months. The survey covers a diverse range of topics including investment preferences, the ODD process, transparency and direct investing. Global Fund Media editor, James Williams (pictured), reports on the survey’s key findings…
Last year’s survey helped alternative fund managers get a steer on how investors viewed them and attracted interest in numerous markets outside of the US. This included the likes of Germany, where one of its leading business newspapers, Handelsblatt,
An affiliate of private equity firm HIG Capital has completed a strategic investment in Assistência Multidisciplinar em Oncologia (AMO), an independent oncology clinic in Brazil and a nationally recognised provider of cancer treatment.
Headquartered in Salvador, and with eight clinics in the State of Bahia, AMO is the largest oncological service provider in the State, offering comprehensive cancer treatments to patients in partnership with a large clinical team and several local hospitals. With recognised quality and patient-centric care, the Company is among a selected group of seven organisations outside the US with a distinguished quality certification from the American Society
Mid-market private equity investor LDC has completed the sale of fume extraction and filtration specialist BOFA International (BOFA) to NYSE-listed Donaldson Company, a worldwide manufacturer of filtration systems and parts.
Donaldson has agreed to acquire an 88 per cent stake in BOFA for GBP79 million, valuing the business at GBP90 million.
BOFA specialises in the design, development and manufacture of fume and dust extraction systems across a range of applications and sectors including laser, electronics, mechanical engineering, printing and 3D printing, pharmaceutical and dental. Its clients include world leading companies such as such as ASM Pacific Technology, Videojet Technologies,
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
